18
Dupuytrens Disease Dupuytrens Disease Dr Steve Carter Dr Steve Carter

Dupuytrens disease

Embed Size (px)

Citation preview

Page 1: Dupuytrens disease

Dupuytrens DiseaseDupuytrens Disease

Dr Steve CarterDr Steve Carter

Page 2: Dupuytrens disease

IntroductionIntroduction Dupuytrens description 1831Dupuytrens description 1831 Plater 1614 Scandinavian literature 1700Plater 1614 Scandinavian literature 1700 Cline proposed fasciectomy in 1787Cline proposed fasciectomy in 1787 Cooper performed first fasciectomy 1822Cooper performed first fasciectomy 1822

Page 3: Dupuytrens disease

EpidemiologyEpidemiology Common in Northern Europe 16% rises to 60% in Common in Northern Europe 16% rises to 60% in

relativesrelatives Associations, diabetes, TB, Aids,Seizure disorders minor Associations, diabetes, TB, Aids,Seizure disorders minor

traumatrauma Essentially Fibroblasts converted to myofibroblasts Essentially Fibroblasts converted to myofibroblasts

Page 4: Dupuytrens disease

Anatomy / PathophysiologyAnatomy / Pathophysiology Palmar fascia triangular shape base at mcpsPalmar fascia triangular shape base at mcps 4 longitudinal bands attached to skin intrinsic muscles4 longitudinal bands attached to skin intrinsic muscles

Page 5: Dupuytrens disease

Anatomy / PathophysiologyAnatomy / Pathophysiology Begins as a palmar noduleBegins as a palmar nodule Extends distally as a cord Type 3 collagen Extends distally as a cord Type 3 collagen

myofibroblastsmyofibroblasts

Page 6: Dupuytrens disease

ClinicalClinical Nodule / contractureNodule / contracture Activities of daily livingActivities of daily living Knuckle padsKnuckle pads Ledderhose Peyronies diseaseLedderhose Peyronies disease Other assoc CTS Trigger fingerOther assoc CTS Trigger finger Differentiation from BoutonniereDifferentiation from Boutonniere

Page 7: Dupuytrens disease

Non operative treatmentNon operative treatment Steroids Anti-inflamatoriesSteroids Anti-inflamatories Clostridium collegenase Clostridium collegenase Mainstay of treatment remains surgicalMainstay of treatment remains surgical

Page 8: Dupuytrens disease

Surgical IndicationsSurgical Indications Activities of daily living, Table top testActivities of daily living, Table top test MCP > 30 degree contractue MCP > 30 degree contractue PIP > 20 Degree contracturePIP > 20 Degree contracture

Page 9: Dupuytrens disease

Surgical IndicationsSurgical Indications

Page 10: Dupuytrens disease

Surgical treatmentSurgical treatment Fasciotomy Fasciotomy

Regional FasciectomyRegional Fasciectomy

Total FasciectomyTotal Fasciectomy

DermatofasciectomyDermatofasciectomy

Segmental AponeurectomySegmental Aponeurectomy

McCash open palm techniqueMcCash open palm technique

Page 11: Dupuytrens disease

Surgical treatmentSurgical treatment Skin IncisionsSkin Incisions

Page 12: Dupuytrens disease

Surgical treatmentSurgical treatment DissectionDissection

Page 13: Dupuytrens disease

Surgical treatmentSurgical treatment Joint releaseJoint release

Page 14: Dupuytrens disease

Surgical treatmentSurgical treatment HeamostasisHeamostasis

Page 15: Dupuytrens disease

Surgical treatmentSurgical treatment Skin ClosureSkin Closure

Page 16: Dupuytrens disease

Surgical treatmentSurgical treatment PostoperativePostoperative

Page 17: Dupuytrens disease

Surgical treatmentSurgical treatment

ComplicationsComplications HeamatomaHeamatoma Skin necrosesSkin necroses InfectionInfection Digital nerve and arteryDigital nerve and artery RSDRSD StiffnessStiffness Loss of strengthLoss of strength RecurrenceRecurrence

Page 18: Dupuytrens disease

ConclusionConclusion